About
Scribe Therapeutics is a biotech company that develops and engineers new therapeutics based on CRISPR. The company’s first technology, called X-Editing (XE) molecules, are highly engineered CRISPR enzymes that provide combined aspects of greater efficacy, specificity, and deliverability than currently available CRISPR genome editing technology. It also a long-term, engineering approach that can help establish CRISPR-based therapies as a new standard of clinical care and expand access to groundbreaking treatments that will impact millions of lives.
Scribe Therapeutics is overcoming the limitations of current genome editing technologies by developing custom-engineered enzymes and delivery modalities as part of a proprietary, evergreen platform for CRISPR-based genetic medicine. The company built for exceptional specificity within the genome – enabling therapeutic precision and allele-specific targeting.
Scribe Therapeutics was founded in 2018 and is headquartered in Alameda, CA, USA.
Mission
Scribe Therapeutics is dedicated to revolutionizing the field of genetic medicine by developing advanced CRISPR-based therapies for a wide range of diseases. Their core mission is to harness the power of cutting-edge genome editing technologies to create life-changing treatments for patients in need. By fostering a culture of innovation, collaboration, and scientific excellence, Scribe Therapeutics aims to make a lasting impact on global healthcare and improve the lives of countless individuals.
Employee Benefits
- Salary commensurate with experience
- Intellectually stimulating, collegial, and fast-paced work environment
- Opportunity to engineer the future of therapeutics
- Commitment to creating a diverse environment
- Equal opportunity employer
- Consideration for employment without regard to race, color, religion, gender, gender identity or expression, sexual orientation, national origin, disability, age, or veteran status
Core Values
- Innovation: Scribe Therapeutics is dedicated to pushing the boundaries of gene editing technology through innovative research and development.
- Collaboration: Collaboration is key at Scribe Therapeutics, where teams work together to solve complex problems and achieve shared goals.
- Integrity: Scribe Therapeutics values integrity above all else, ensuring that all research and business practices are conducted with honesty and transparency.
- Diversity and Inclusion: Scribe Therapeutics is committed to fostering a diverse and inclusive workplace, where all employees feel valued and supported.
- Impact: Scribe Therapeutics strives to make a positive impact on the world through its groundbreaking gene editing technology and dedication to improving human health.
Scribe Therapeutics
Leadership
David F. Savage
Co-Founder
David Parrot
CFO
Brett Staahl
Co-Founder and VP of Platform
Open Jobs
No items found.